| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |